Medications for Severe Combined Immunodeficiency

5 results

  • Bivigam

    (Immune Globulin Intravenous (Human) 10%)
    ADMA Biologics, Inc.
    Usage: BIVIGAM is indicated for treating primary humoral immunodeficiency (PI) in adults and children aged 2 years and older. It addresses conditions such as common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

  • Cutaquig

    (immunoglobulin G)
    Pfizer Laboratories Div Pfizer Inc
    Usage: CUTAQUIG is indicated for replacement therapy in primary humoral immunodeficiency in adults and children aged 2 and older. Conditions include common variable immunodeficiency, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

  • Cuvitru

    (Immune Globulin Subcutaneous (Human))
    Takeda Pharmaceuticals America, Inc.
    Usage: CUVITRU is indicated for replacement therapy in primary humoral immunodeficiency (PI) in patients aged two years and older. Conditions treated include common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

  • Flebogamma

    (Immune Globulin (Human))
    GRIFOLS USA, LLC
    Usage: Flebogamma 5% DIF is an intravenous immune globulin indicated for adults and children aged 2 and older to treat primary immunodeficiency, including conditions like common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich syndrome.

  • Yimmugo (immune globulin intravenous, human - dira)

    (immune globulin intravenous, human - dira)
    Biotest AG
    Usage: YIMMUGO is indicated for treating primary humoral immunodeficiency (PI) in patients aged 2 and older, including conditions such as congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia (XLA), Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).